---
figid: PMC4097325__11307_2014_735_Fig3_HTML
figtitle: FAC PET probe analogs and gemcitabine
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC4097325
filename: 11307_2014_735_Fig3_HTML.jpg
figlink: /pmc/articles/PMC4097325/figure/Fig3/
number: F3
caption: FAC PET probe analogs and gemcitabine. The FAC tracer dose used in PET studies
  is 2.4 × 10−5–2.4 × 10−7 times the therapeutic dose of gemcitabine []. FAC and gemcitabine
  follow the same transport and biochemical pathway in normal and cancer cells and
  are activated through phosphorylation by the enzyme dCK. Reprinted with permission
  of Springer [].
papertitle: INDs for PET Molecular Imaging Probes—Approach by an Academic Institution.
reftext: Sherly Mosessian, et al. Mol Imaging Biol. 2014;16(4):441-448.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9059822
figid_alias: PMC4097325__F3
figtype: Figure
redirect_from: /figures/PMC4097325__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4097325__11307_2014_735_Fig3_HTML.html
  '@type': Dataset
  description: FAC PET probe analogs and gemcitabine. The FAC tracer dose used in
    PET studies is 2.4 × 10−5–2.4 × 10−7 times the therapeutic dose of gemcitabine
    []. FAC and gemcitabine follow the same transport and biochemical pathway in normal
    and cancer cells and are activated through phosphorylation by the enzyme dCK.
    Reprinted with permission of Springer [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - fax
  - E(spl)mgamma-HLH
  - mas
  - myoblast-specific
  - S6KL
  - dock
  - sti
  - CaMKII
  - Uf
  - L-[18F]-FMAC
  - Gemcitabine
  - gemcitabine
  - dFdC D-[18F]-FAC
  - dFdC-MP D-[18F]-FAC
---
